pharmanewsdaily

This user hasn't shared any profile information

By pharmanewsdaily On Sunday, May 17th, 2020
0 Comments

Takeda gets extended EC approval for ADCETRIS in sALCL

Takeda Pharmaceutical has secured extended approval for ADCETRIS (brentuximab vedotin) in the European Union to include the treatment of previously untreated systemic anaplastic large cell lymphoma (sALCL) in adult More...

By pharmanewsdaily On Sunday, May 17th, 2020
0 Comments

Gesynta Pharma reports positive results for GS-248 phase 1 study

Swedish pharma company Gesynta Pharma has reported positive results from the phase 1 clinical trial of GS-248, which is being developed for the treatment of microvascular diseases in chronic inflammatory conditions. The More...

By pharmanewsdaily On Sunday, May 17th, 2020
0 Comments

Deciphera gets Qinlock FDA approval for fourth-line advanced GIST

Qinlock FDA approval : Deciphera Pharmaceuticals has been granted approval from the US Food and Drug Administration (FDA) for Qinlock (ripretinib) in advanced gastrointestinal stromal tumor (GIST) in adult patients More...

By pharmanewsdaily On Friday, May 15th, 2020
0 Comments

FDA rejects Blueprint’s NDA for AYVAKIT for treatment of fourth-line GIST

Blueprint Medicines said that the US Food and Drug Administration (FDA) has rejected its new drug application (NDA) for AYVAKIT (avapritinib) for the treatment of fourth-line gastrointestinal stromal tumor (GIST). The More...

By pharmanewsdaily On Friday, May 15th, 2020
0 Comments

Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus

Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration. The US More...

By pharmanewsdaily On Wednesday, May 13th, 2020
0 Comments

Rohatyn Group completes investment in Croatian CRO Optimapharm

The Rohatyn Group (TRG), a US asset management firm focusing on emerging markets, has completed an investment in Optimapharm, a contract research organization (CRO) based in Croatia. The Croatian CRO, which was More...

By pharmanewsdaily On Tuesday, May 12th, 2020
0 Comments

Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system

Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 IgG lab-based serology blood test, a COVID-19 antibody blood test, on the Alinity i system. The More...

By pharmanewsdaily On Tuesday, May 12th, 2020
0 Comments

HKBU-led researchers develop EBV drug for nasopharyngeal cancer

A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus (EBV) drug for the treatment of nasopharyngeal cancer and other EBV-related cancers. The novel More...

By pharmanewsdaily On Saturday, May 9th, 2020
0 Comments

AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan

US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following receipt of all the required approvals from all government authorities and approval More...

By pharmanewsdaily On Saturday, May 9th, 2020
0 Comments

Selpercatinib FDA approval : Lilly’s therapy approved for treatment of lung and thyroid cancers with RET alteration

Selpercatinib FDA approval : The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Retevmo (selpercatinib) capsules for the treatment of three types of tumors – non-small cell lung More...